Syntheses and properties of kanamycin C derivatives active against resistant bacteria.

نویسندگان

  • S Kondo
  • T Miyasaka
  • K Yoshida
  • K Iinuma
  • H Umezawa
چکیده

Sir: The enzymatic mechanism of resistance to aminoglycoside antibiotics has been explored by UMEZAWA.1,2) Many clinically isolated strains of aminoglycosides-resistant bacteria produce enzymes which phosphorylate, adenylylate or acetylate specific positions of aminoglycoside antibiotics. Kanamycin and kanamycin B are inactivated by aminoglycoside 3'-phosphotransferases, 2"-nucleotidyltransferase or 6'acetyltransferases. Furthermore, it has been shown that the 3'-phosphotransferase-producing bacteria are inhibited by 3'-deoxy derivatives of these antibiotics and 2"-nucleotidyl transferaseproducing bacteria by the 1-N-[(S)-4-amino-2hydroxybutyryl] derivatives. However, the 6'modification of these antibiotics has not yet produced derivatives which inhibit all 6'-acetyltransferase-producing strains.31 Kanamycin C isolated from a culture filtrate of Streptomyces kanamrceticus as a minor component has the 6'hydroxyl in place of the 6'-amino group in kanamycin B, and is not inactivated by 6'-acetyltransferases. In this communication, we report chemical conversion of kanamycin B and its deoxy derivatives into kanamycin C and its deoxy derivatives, and synthesis of their I-N-[(S)-4amino-2-hydroxybutyryl] derivatives. Kanamycin B was converted into kanamycin C (1) in good yield by the following route. The free amino groups of 6'-N-BOC*-kanamycin B monohydrate4) were acetylated with acetic anhydride in methanol at room temperature for 5 hours and the BOC group was removed in 90 trifluoroacetic acid at room temperature for 45 minutes. The 1,3,2',3"-tetra-N-acetylkanamycin B trifluoroacetate thus obtained was treated with sodium nitrite in 33 % aqueous acetic acid for 1 hour at ice temperature and then for 2 hours at room temperature. The reaction mixture was concentrated to dryness and the residue was dissolved in 2 N NaOH. After refluxing the alkaline solution for 12.5 hours, I in the solution was adsorbed on a column of Amberlite CG-50 (70% NH4+) resin and eluted with 0.5 N ammonia. Rechromatography on a Amberlite CG-50 (NH4+) column eluted with 0.05 N, 0.1 N and then O.2 N ammonia gave pure I in 49 yield. The deoxy derivatives, 3'-deoxykanamycin C (II) and 3',4'-dideoxykanamycin C (III) were synthesized from 6'-N-BOC-3'-deoxykanamycin B** and 6'-N-BOC-3',4'-dideoxykanamycin B6) by the method described above in 40 % and 24 yields, respectively. The 1-N-acyl derivatives with (S)-4-amino-2hydroxybutyric acid were synthesized from partially protonated forms of I, II and III without any protection of amino groups. In an aqueous solution at pH 6.5±0.2 adjusted with 1 N HCI, I, II or III was acylated with 1.5 equivalents of the N-hydroxysuccinimide ester of N-BOC-(S)-4-amino-2-hydroxybutyric acid6) in dimethylformamide at room temperature for 6 hours and then the BOC group was removed in 90% trifluoroacetic acid at room temperature for 1 hour to afford I-N-[(S)-4-amino-2-hydroxybutyryl]-kanamycin C (IV), -3'-deoxykanamycin C (V) or -3',4'-dideoxykanamycin C (VI) in 8.0 %, 8.5 % or 8.3 % yield, respectively. These derivatives were purified by column chromatography on Amberlite CG-50 (NH4+) resin eluted with 0.2 N and 0.5 N ammonia, and on silica gel (Mallinckrodt, CC-7) developed with a mixture of chloroform, methanol and 17% ammonia (1: 4: 2 in volume). With the resin chromatography, unreacted I, II or III was recovered in 40%, 34°0 or 45% yield, respectively. From the silica gel chromatography, a positional isomer having weak biological activity, 3-N-[(S)-4amino-2-hydroxybutyryl]-kanamycin C(VII), -3'deoxykanamycin C (VIII) or -3',4'-dideoxykanamycin C (IX) was separated in 11.0%, 6.1 °„ or 7.4% yield, respectively. The properties of all derivatives described above are summarized in Table 1. The structures of the acyl derivatives were confirmed by PMR and acid hydrolysis". On the carbon-13 FouRtaR-transform NMR spectra of I, IV, V, VI and VII, the chemical shifts were assigned as shown in Table 2." The minimum inhibitory concentration of I and its five derivatives are shown in Table 3.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Synthesis of 3',4'-dideoxy and 3',4',5''-trideoxyribostamycin active against kanamycin-resistant E. coli and P. aeruginosa.

cin B2) and S'^-dideoxyneamine^ have confirmed that removal of the hydroxyl group which is phosphorylated by drug-resistant bacteria from kanamycins gives compounds active against the resistant organisms. As an extension of this work, we describe in this paper the syntheses of two deoxy-derivatives of ribostamycin4). If inactivation of ribostamycin by Escherichia coli K12-ML 1629 and K12-ML 163...

متن کامل

Syntheses of Substituted 1,3,4-Oxadiazole, 1,3,4-Thiadiazole and 1,2,4-Triazole Derivatives as Potential Antimicrobial Agents

A series of 2-(4-nitro-1-imidazolylmethyl)-1,3,4-oxadiazole, 1,3,4-triazole and 3-(4-nitro-1-imidazolylmethyl)-1,2,4-triazole derivatives were synthesized and tested for their antimicrobial activity. Some of the tested compounds were active against Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Clostridium difficile, Aspergillus niger and Cryptococcus neoformans.

متن کامل

The kanamycin biosynthetic gene cluster from Streptomyces kanamyceticus.

Kanamycin is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus1). Although it possesses broad range antibacterial activity, bacteria resistant to this antibiotic readily appear, and therefore its clinical use has been restricted to tuberculosis. Resistant bacteria inactivate kanamycin by modifying its specific aminoor hydroxygroup using acetyltransferase, phosphotransferase an...

متن کامل

Synthesis of 3'-deoxy-3'-fluorokanamycins A and B active against resistant bacteria.

Sir: Kanamycins are inactivated by enzymes of resistant bacteria phosphorylating or adenylylating the 3', 4' or 2"-hydroxyl groups' 21 , among which the 3'-hydroxyl group is most frequently modified. Syntheses of 3'-deoxykanamycin A3), 3',4'-dide-oxykanamycin B4) (dibekacine), and other deoxy derivatives of kanamycins and related aminogly-coside antibiotics were the major solution"" in order to...

متن کامل

In vitro studies with UK-18,892, a new aminoglycoside antibiotic.

The antibacterial activity of UK-18,892, a new semisynthetic aminoglycoside, was examined against aminoglycoside-susceptible and aminoglycoside-resistant clinical isolates of gram-negative bacilli and Staphylococcus aureus. UK-18,892 had a similar degree of activity to those of amikacin and kanamycin A against aminoglycoside-susceptible bacteria but was less potent than gentamicin against all i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of antibiotics

دوره 30 12  شماره 

صفحات  -

تاریخ انتشار 1977